BridgeMD
New treatment option for Stroke Ischemic
Official title BREMISS : Brain Resilience Minor Stroke Study
ClinicalTrials.gov ID: NCT06995040
What this study is testing
What is saliva sample?
saliva sample is an investigational medicine, being studied as a potential treatment for stroke ischemic.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The objective of this clinical trial is to develop, based on patients' initial characteristics (in the first few weeks following the stroke), a predictive model of quality of life more than 4 years after the stroke in patients who have suffered a minor ischemic stroke. The main question it aims to answer is: \- Is it possible to predict the quality of life of patients who have suffered a minor ischemic stroke based on their initial characteristics?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Cases of stroke in the Brest Stroke Registry (BSR)
- Ability to sign informed consent
- Patients followed-up \> 4 years during the study period
- NIHSS score ≤ 5 on admission
- First stroke above 18 and before 75-year old
You likely can't join if
- Patients with transient neurological deficits resolving within one hour and normal brain imaging will be excluded.
- Not affiliated to social security
- Patient under legal protection or deprived of liberty by a judicial or administrative decision
- Patient unable to sign informed consent
- Patient whose follow-up will be impossible
See the full eligibility criteria
- Cases of stroke in the Brest Stroke Registry (BSR)
- Ability to sign informed consent
- Patients followed-up \> 4 years during the study period
- NIHSS score ≤ 5 on admission
- First stroke above 18 and before 75-year old
- Rankin before stroke \< 1
- Possibility to draw saliva samples for genomic study
- Possibility to perform Cerebral MRI
- Patients with transient neurological deficits resolving within one hour and normal brain imaging will be excluded.
- Not affiliated to social security
- Patient under legal protection or deprived of liberty by a judicial or administrative decision
- Patient unable to sign informed consent
- Patient whose follow-up will be impossible
The study team makes the final eligibility decision.
Where it's taking place
- Brest, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brest, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.